Stay updated on Magrolimab Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Magrolimab Combo in AML Clinical Trial page.

Latest updates to the Magrolimab Combo in AML Clinical Trial page
- Check2 days agoChange DetectedLocations section updated with numerous state and national sites and a new revision tag v3.3.3. Some locations were removed or reorganized.SummaryDifference1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedAdded a note clarifying that PubMed publications are automatically filled and may not all pertain to the study, and updated the revision label to v3.3.2 (replacing v3.2.0).SummaryDifference0.0%

- Check38 days agoChange DetectedThe notice about a lapse in government funding and NIH Clinical Center operating status has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedA minor update adds study record dates indicating when results were posted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference2%

- Check88 days agoChange DetectedAdditions introduce revision v3.1.0; deletions remove several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and include an older version tag v3.0.2. The page’s scope appears to contract around safety topics while updating its version.SummaryDifference0.2%

Stay in the know with updates to Magrolimab Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab Combo in AML Clinical Trial page.